Se-cure Pharmaceuticals Ltd.   Report issue

For profit
Founded: Airport City Israel (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2011
NCT01502527
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Se-cure Pharmaceuticals Ltd.

Active Ingredients

Drugs in Other Trials (2)

flaxseed (2 trials)

soy extract (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2